EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 105 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,898 | -3.7% | 3,196 | -9.9% | 0.00% | – |
| Q1 2024 | $18,591 | -48.0% | 3,548 | -48.1% | 0.00% | – |
| Q4 2023 | $35,779 | +140.1% | 6,841 | +623.9% | 0.00% | – |
| Q3 2023 | $14,902 | -33.7% | 945 | -18.3% | 0.00% | -100.0% |
| Q2 2023 | $22,492 | +224820.0% | 1,157 | +217.0% | 0.00% | – |
| Q1 2023 | $10 | 0.0% | 365 | +2.2% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 357 | -95.5% | 0.00% | -100.0% |
| Q3 2022 | $211,000 | +305.8% | 7,957 | +578.3% | 0.00% | +200.0% |
| Q2 2022 | $52,000 | -59.7% | 1,173 | -55.2% | 0.00% | 0.0% |
| Q1 2022 | $129,000 | -33.5% | 2,617 | -31.2% | 0.00% | -66.7% |
| Q4 2021 | $194,000 | +203.1% | 3,805 | +230.6% | 0.00% | +50.0% |
| Q3 2021 | $64,000 | +93.9% | 1,151 | +50.3% | 0.00% | +100.0% |
| Q2 2021 | $33,000 | -21.4% | 766 | -24.7% | 0.00% | 0.0% |
| Q1 2021 | $42,000 | +366.7% | 1,017 | +441.0% | 0.00% | – |
| Q4 2020 | $9,000 | -71.9% | 188 | -75.4% | 0.00% | – |
| Q3 2020 | $32,000 | -67.7% | 765 | -63.0% | 0.00% | -100.0% |
| Q2 2020 | $99,000 | +2375.0% | 2,066 | +1886.5% | 0.00% | – |
| Q4 2018 | $4,000 | -85.2% | 104 | -71.3% | 0.00% | -100.0% |
| Q2 2018 | $27,000 | -73.8% | 362 | -81.5% | 0.00% | -77.8% |
| Q1 2018 | $103,000 | +692.3% | 1,958 | +695.9% | 0.01% | +350.0% |
| Q4 2017 | $13,000 | -59.4% | 246 | -37.1% | 0.00% | -33.3% |
| Q1 2017 | $32,000 | -68.9% | 391 | -69.9% | 0.00% | -72.7% |
| Q4 2016 | $103,000 | +10200.0% | 1,300 | +4233.3% | 0.01% | – |
| Q1 2016 | $1,000 | -88.9% | 30 | -70.0% | 0.00% | -100.0% |
| Q4 2015 | $9,000 | -87.3% | 100 | -89.5% | 0.00% | -85.7% |
| Q3 2015 | $71,000 | +1320.0% | 954 | +657.1% | 0.01% | +600.0% |
| Q1 2015 | $5,000 | +25.0% | 126 | -52.8% | 0.00% | – |
| Q4 2014 | $4,000 | -84.0% | 267 | -86.4% | 0.00% | -100.0% |
| Q3 2014 | $25,000 | +212.5% | 1,966 | +222.3% | 0.00% | +200.0% |
| Q1 2014 | $8,000 | – | 610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |